Establishment Labs Holdings Inc (FRA:3E0)
€ 41.8 -1.4 (-3.24%) Market Cap: 1.18 Bil Enterprise Value: 1.33 Bil PE Ratio: 0 PB Ratio: 38.76 GF Score: 77/100

Establishment Labs Holdings Inc at UBS Global Healthcare Conference (Virtual) Transcript

May 18, 2020 / 07:00PM GMT
Release Date Price: €14.5 (-5.84%)
Matthew Charles Taylor
UBS Investment Bank, Research Division - Equity Research Analyst of Medical Supplies & Devices

Great. Good afternoon, and thanks, everybody, for joining us for our next session here in the MedTech Track. I'm Matt Taylor, UBS' U.S. medical supplies and devices analyst, and I'm really pleased to be joined by the management team from Establishment Labs Holdings. And today, we'll have a Q&A session for about 40 minutes moderated by me, but if you have any questions, you can e-mail me or send your questions through the app link. So on the line, we've got a few members of the management team here. We've got J.J. Chacon Quiros, who's the CEO and founder of Establishment. We've also got Renee Gaeta, who's the CFO and David Erickson, who is heading up the IR function for the group. And first, I just want to thank everybody for joining us, and say, welcome to the call.

Juan JosÃ;Chacón Quirós
Establishment Labs Holdings Inc. - Founder, CEO & Executive Director

© -

Thank you.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot